SkyQuest Technology Group has recently published a comprehensive Proteomics Market report, offering a detailed analysis of the product landscape and industry scope while providing insights into the market outlook and future trends from 2025 to 2032. The global proteomics market is experiencing strong growth, driven by increasing investments in personalized medicine, improving protein analysis technologies, and the increasing prevalence of infectious and chronic diseases. As healthcare systems move toward precision medicine, proteomics is becoming a central element in the discovery of disease-specific biomarkers, enabling targeted treatments, and improving diagnostic accuracy.
Global Proteomics Market size was valued at USD 31.8 billion in 2023 and is poised to grow from USD 36.16 billion in 2024 to USD 100.99 billion by 2032, growing at a CAGR of 13.7% during the forecast period (2025-2032).
Advances in technologies related to liquid chromatography, mass spectrometry, and protein microarrays have facilitated the speed and accuracy of proteomic methods to a level where biotech and pharmaceutical organizations are now willing to adopt these methods for drug development and discovery. Public and private investments, especially in the North American, European, and Asia-Pacific regions, are driving research and development in this field.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/proteomics-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Proteomics Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Proteomics Market is segmented by Instrumentation Technology, Reagent, Service, Software, Application, End-User and region.
Based on Instrumentation Technology, the market is segmented into Spectroscopy, Chromatography, Electrophoresis, Microarray Technologies and Other Instrumentation Technologies.
Based on Reagent, the market is segmented into Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Electrophoresis Reagents, Microarray Reagents, X-Ray Crystallography Reagents, Protein Fractionation Reagents and Other Reagents.
Based on Service, the market is segmented into Core Proteomics Services and Bioinformatics Services.
Based on Software, the market is segmented into Bioinformatics Tools and Bioinformatics Databases.
Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Other Applications.
Based on End-User, the market is segmented into Biopharmaceutical & Biotechnology Companies, Academic And Research Institutes, Hospitals, Clinical & Diagnostic Laboratories and Other End Users.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Proteomics Market – Regional Analysis:
North America remains the dominant geography in the proteomics industry worldwide, fueled by robust biomedical infrastructure, significant public-private investments in life sciences, and increasing demand for personalized medicine. Robust academic and clinical research environments are a major driver for driving technological innovation, particularly in proteomic data analysis and biomarker discovery. Interdisciplinary interactions between academia, healthcare, and industry continue to fuel the advancement of clinical proteomics applications, primarily in cancer, neurology, and the management of chronic diseases.
In 2024, the US proteomics sector witnessed a noteworthy boost when Thermo Fisher Scientific announced its $3.1 billion acquisition of Olink Holding AB, enhancing the country’s strength in precision proteomics and biomarker discovery.
Europe is the fastest growing region in the proteomics market, fueled by large-scale government funding, integrated health research systems, and strong pharmaceutical industry support. The region prioritizes translational research and multi-omics approaches, with growing investment in proteomics for clinical diagnostics, vaccine development, and drug target validation.
Asia Pacific is becoming a prominent region in the global proteomics market, driven by strong government support, rising healthcare investments, and advancements in precision medicine. Japan and South Korea lead with innovative research in protein diagnostics and targeted therapies. Major centers in Tokyo, Osaka, and Seoul are expanding proteomics applications in oncology and neurology.
Top Market Players in Proteomics Market are:
Thermo Fisher Scientific
Creative Diagnostics
Agilent Technologies
Bruker Corporation
Danaher Corporation
Waters Corporation
Bio-Rad Laboratories
PerkinElmer
Creative Proteomics
Promega Corporation
LI-COR Biosciences
Horiba Ltd
Illumina, Inc.
SomaLogic
NanoString Technologies
Proteome Sciences
Shimadzu Corporation
Merck KGaA
Enzo Life Sciences
Akoya Biosciences
Recent Developments in Proteomics Market:
Sapient announced a partnership with Alamar Biosciences in January 2025 to enhance its targeted proteomics services using Alamar’s high-sensitivity NULISA™ assays. This collaboration enables precise detection of low-abundance cytokines, chemokines, and neuroinflammatory biomarkers, supporting drug discovery and development.
Quantum-Si announced the launch of Platinum® Pro in January 2025, an advanced benchtop protein sequencer designed to streamline and deepen proteomics research. Building on its original Platinum system, Platinum Pro offers enhanced user experience, flexible data analysis options, and custom application development through its Pro Mode.
On January 2025, Quantum-Si announced a partnership with IDEX Health & Science to develop and manufacture the optics module for its upcoming Proteus™ proteomics platform. The collaboration combines Quantum-Si’s expertise in protein sequencing with IDEX’s leadership in life science optics, aiming to accelerate the launch of Proteus by late 2026.
You may Also Like
https://issuu.com/skyquest-technology/docs/how_is_the_global_demand_for_badminton_equipment_d
https://issuu.com/skyquest-technology/docs/empty_capsules_market_to_witness_promising_growth_
Forward-Looking Insights
The Proteomics Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
